Sex differences in non-reproductive cancers: mechanistic roles of sex-hormone signaling.

Authors

Jingsheng Xu, Xinyu Zhang, Zhenyu Li, Siqi Li, Anhui Ning, Dingding Li, Minjie Chu, Haiyan Gong

Published in

Cell communication and signaling : CCS. Jul 04, 2026. Epub Jul 04, 2026.

Abstract

Sex differences in the incidence and outcomes of non-reproductive cancers persist across many tumor types, even after adjustment for major exposure- and care-related factors. This review examines how sex-hormone signaling may contribute to these patterns through tumor-intrinsic mechanisms and regulation of the tumor microenvironment. In tumor cells, ER, AR and PR mediate classical nuclear transcriptional programs, whereas membrane-associated or cytoplasmic receptor pools, together with GPER, support rapid non-genomic signaling through PI3K/AKT, MAPK/ERK and related kinase or second-messenger pathways. Intratumoral steroid handling can create local ligand conditions that differ from circulating hormone levels and modify context-specific receptor activity. Hormonal context may also influence vascular, stromal and immune phenotypes. Clinically, sex-hormone-related tumor states may be better captured by integrated activity-based readouts, including receptor status, pathway activation, local steroid availability and immune context, rather than receptor immunostaining alone. Overall, sex-hormone signaling offers a hypothesis-generating framework for understanding sex-biased tumor biology beyond traditional hormone-driven cancers, but its clinical relevance requires further mechanistic and prospective validation.

PMID:
42401911
Bibliographic data and abstract were imported from PubMed on 05 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.